# US 2024/0175820 A1 · Quantitative hormone and chemical analyte test result systems and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0175820 A1
- Document ID: US20240175820A1
- Status: Published application
- Kind: A1
- Application number: 18/433,900
- Filed: 2024-02-06
- Published: 2024-05-30
- Earliest claimed: 2020-06-02
- Assignees: Easy Healthcare Corporation
- Applicants: Easy Healthcare Corporation
- Inventors: Xiaolian Liu; Li Zou
- Web page: https://patentgrep.com/patent/US20240175820A1

## CPC

- G01N 21/78: producing a change of colour
- A61B 10/0012: {Ovulation-period determination (for animals A61D17/002)}
- A61B 10/007: {for taking urine samples (measuring urological functions A61B5/20; genital receptacles A61F5/451; urinals for bed-ridden persons A61G9/006)}
- G01N 21/8483: {Investigating reagent band (test-element handling not specific to a test method G01N33/4875; analytical elements specific to chemical analysis of biological material G01N33/52; autometer with reagent band G01N35/04)}
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- G01N 33/743: {Steroid hormones}
- G01N 33/76: Human chorionic gonadotropin {including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors}
- G06T 11/26: Drawing of charts or graphs
- G06V 10/44: Local feature extraction by analysis of parts of the pattern, e.g. by detecting edges, contours, loops, corners, strokes or intersections; Connectivity analysis, e.g. of connected components
- G06V 10/56: relating to colour
- G06V 20/00: Scenes; Scene-specific elements (control of digital cameras H04N23/60)
- G06V 20/52: Surveillance or monitoring of activities, e.g. for recognising suspicious objects (recognising microscopic objects G06V20/69)
- A61B 2010/0006: {involving a colour change}
- G01N 33/54388: {based on lateral flow}
- G01N 2021/7759: {Dipstick; Test strip}
- G06T 2210/41: Medical
- G06V 2201/034: of medical instruments
- G06V 2201/10: Recognition assisted with metadata
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06V: IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING

## Abstract

Systems, methods, and apparatus are disclosed for determining quantitative hormone and chemical analyte results from qualitative test results. An image is taken of a test device. The image is analyzed to identify a darkness intensity ratio (T/C ratio) between a darkness value of a test-line to a darkness value of a control-line. Additionally, a quantitative substance level may be determined using the T/C ratio, by identifying the type of test device and referencing a data structure that relates quantitative substance levels to T/C ratios for the identified type of test device.

## Claims

### Claim 1

A testing system comprising:
a test device including a test area including a visually identifiable test-line and a visually identifiable control-line formed in response to exposure to a tested substance; and
a user device including a camera, a processor, a display, and memory storing program instructions, wherein, in response to executing the program instructions, the processor:
receives an image of the test device from the camera, the image including the test area, the visually identifiable test-line, and the visually identifiable control-line;
determines a numerical test-line value and a numerical control-line value based on the visually identifiable test-line and the visually identifiable control-line, respectively;
calculates a T/C ratio defined as a relative value of the numerical test-line value to the numerical control-line value;
translates the T/C ratio into a quantitative level of a substance;
analyzes data points, wherein the data points include the T/C ratio and/or quantitative level of the substance and additional T/C ratios and/or additional quantitative levels of other substances; and
presents information indicative of the data points, wherein the information includes a calendar and/or a graph including an ovulation cycle and/or hormone changes.

### Claim 2 (depends on 1)

The system of claim 1, wherein the information includes the ovulation cycle and/or the hormone changes over a plurality of months.

### Claim 3 (depends on 2)

The system of claim 2, wherein the information comprises a prediction of a fertility window, peak predicted fertility days, or period days.

### Claim 4 (depends on 1)

The system of claim 1, further comprising a plurality of test devices, each test device including a test area including a visually identifiable test-line and a visually identifiable control-line formed in response to exposure to a tested substance, wherein the processor is configured to:
receive a plurality of images of the test devices from the camera, each image including the test area, the visually identifiable test-line, and the visually identifiable control-line;
determine a numerical test-line value and a numerical control-line value based on the visually identifiable test-line and the visually identifiable control-line, respectively, for each image;
calculate a T/C ratio for each image, the T/C ratio defined as a relative value of the numerical test-line value to the numerical control-line value;
translate each T/C ratio into a quantitative level of a substance, wherein the data points include each T/C ratio and/or quantitative level; and
present the information indicative of the data points.

### Claim 5 (depends on 4)

The system of claim 4, wherein, in response to executing the program instructions, the processor further:
creates, for each image, a test-line greyscale representation of the visually identifiable test-line and a control-line greyscale representation of the visually identifiable control-line;
determines, for each image, a numerical test-line value based on a test-line darkness value of the test-line greyscale representation of the visually identifiable test-line; and
determines, for each image, a numerical control-line value based on a test-line darkness value of the test-line greyscale representation of the visually identifiable test-line.

### Claim 6 (depends on 5)

The system of claim 5, wherein, in response to executing the program instructions, the processor further:
creates, for each image, a second test-line greyscale representation of a second visually identifiable test-line;
determines, for each image, a second numerical test-line value by comparing a second test-line darkness value of the second test-line greyscale representation of the second visually identifiable test-line to the background of the test area to control for the ambient interference and lighting conditions; and
calculates, for each image, a second T/C ratio defined as a second relative value of the second numerical test-line value to the numerical control-line value.

### Claim 7 (depends on 1)

The system of claim 1, wherein the test device is one of an ovulation, pregnancy, progesterone, estrogen, estriol, follicle-stimulating hormone, or other hormone or chemical analyte test device.

### Claim 8 (depends on 1)

The system of claim 1, wherein the tested substance is one of urine, blood, and saliva.

### Claim 9 (depends on 1)

The system of claim 1, wherein, in response to executing the program instructions, the processor selects the image from a stream of images received from the camera.

### Claim 10 (depends on 1)

The system of claim 1, wherein the image includes a visually identifiable portion of the test device, further wherein, in response to executing the program instructions, the processor identifies a model of the test device based on the visually identifiable portion of the test device.

### Claim 11 (depends on 10)

The system of claim 10, wherein the processor identifies the visually identifiable test-line and the visually identifiable control-line by identifying a location, edges, and a line width within the test area that correspond to a defined test-line and a defined control-line for the identified model of the test device.

### Claim 12 (depends on 1)

The system of claim 1, wherein the memory stores a data structure that relates the T/C ratio to the quantitative levels of the substance.

### Claim 13 (depends on 12)

The system of claim 12, wherein a characteristic being tested is the presence of one or more of a luteinizing hormone, a human chorionic gonadotropin, progesterone, estrogen, estriol, a follicle-stimulating hormone, and other hormone or chemical analyte in the tested substance.

### Claim 14

A testing system comprising:
a test device including a test area including a visually identifiable test line and a visually identifiable control line formed in response to exposure to a tested substance; and
a camera, including an image capture mechanism and a camera communication interface;
a processor, including an image processing mechanism and a processor communication interface in communication with the camera communication interface; and
a display controlled by the processor;
wherein, in response to executing the program instructions, the processor:
receives an image of the test device from the camera, the image including the test area, the visually identifiable test-line, and the visually identifiable control-line;
determines a numerical test-line value and a numerical control-line value based on the visually identifiable test-line and the visually identifiable control-line, respectively;
calculates a T/C ratio defined as a relative value of the numerical test-line value to the numerical control-line value;
translates the T/C ratio into a quantitative level of a substance;
analyzes data points, wherein the data points include the T/C ratio and/or the quantitative level of the substance and additional T/C ratios and/or additional quantitative levels of other substances; and
presents information indicative of the data points, wherein the information includes a calendar and/or a graph including an ovulation cycle and/or hormone changes.

### Claim 15 (depends on 14)

The testing system of claim 14, wherein the information comprises the ovulation cycle and/or the hormone changes over a plurality of months.

### Claim 16 (depends on 14)

The testing system of claim 14, wherein the information comprises a prediction of a fertility window, peak predicted fertility days, or period days.

### Claim 17 (depends on 14)

The testing system of claim 14, further comprising a plurality of test devices, each test device including a test area including a visually identifiable test-line and a visually identifiable control-line formed in response to exposure to a tested substance, wherein the processor is configured to:
receive a plurality of images of the test devices from the camera, each image including the test area, the visually identifiable test-line, and the visually identifiable control-line;
determine a numerical test-line value and a numerical control-line value based on the visually identifiable test-line and the visually identifiable control-line, respectively, for each image;
calculate a T/C ratio for each image, the T/C ratio defined as a relative value of the numerical test-line value to the numerical control-line value;
translate each T/C ratio into a quantitative level of a substance, wherein the data points include each T/C ratio and/or quantitative level; and
present the information indicative of the data points.

### Claim 18 (depends on 17)

The testing system of claim 17, wherein, in response to executing the program instructions, the processor further:
creates, for each image, a test-line greyscale representation of the visually identifiable test-line and a control-line greyscale representation of the visually identifiable control-line;
determines, for each image, a numerical test-line value based on a test-line darkness value of the test-line greyscale representation of the visually identifiable test-line; and
determines, for each image, a numerical control-line value based on a test-line darkness value of the test-line greyscale representation of the visually identifiable test-line.

### Claim 19 (depends on 18)

The testing system of claim 18, wherein, in response to executing the program instructions, the processor further:
creates, for each image, a second test-line greyscale representation of a second visually identifiable test-line;
determines, for each image, a second numerical test-line value by comparing a second test-line darkness value of the second test-line greyscale representation of the second visually identifiable test-line to the background of the test area to control for ambient interference and lighting conditions; and
calculates, for each image, a T/C ratio defined as a second relative value of the second numerical test-line value to the numerical control-line value.

### Claim 20 (depends on 14)

The testing system of claim 14, wherein the test device is one of an ovulation, pregnancy, progesterone, estrogen, estriol, follicle-stimulating hormone, or other hormone or chemical analyte test device.

### Claim 21 (depends on 14)

The testing system of claim 14, wherein the tested substance is one of urine, blood, and saliva.

### Claim 22 (depends on 14)

The testing system of claim 14, wherein, in response to executing the program instructions, the processor selects the image from a stream of images received from the camera.

### Claim 23 (depends on 14)

The testing system of claim 14, wherein the image includes a visually identifiable portion of the test device, further wherein, in response to executing the program instructions, the processor identifies a model of the test device based on the visually identifiable portion of the test device.

### Claim 24 (depends on 14)

The testing system of claim 14, wherein the memory stores a data structure that relates the T/C ratio to the quantitative levels of the substance.

### Claim 25 (depends on 24)

The testing system of claim 24, wherein a characteristic being tested is the presence of one or more of a luteinizing hormone, a human chorionic gonadotropin, progesterone, estrogen, estriol, a follicle-stimulating hormone, and other hormone or chemical analyte in the tested substance.
